Sources: some potential Oura IPO investors decided to hold off, citing its ~$15B target valuation and poor post-listing performance of peers like Fitbit (Bloomberg)

Some investors are resisting Oura’s delayed IPO because its roughly $15 billion valuation appears rich relative to public-market comparables and the weak post-IPO performance of peers like Fitbit. For CIOs and technology leaders, the story underscores how growth-tech valuations are increasingly being judged against clearer paths to profitability and public-market discipline, which can affect vendor financing, partnership stability, and ecosystem confidence. IT organizations should expect more scrutiny of digital health and wearables companies’ unit economics, not just their product traction and data capabilities.